Approaching Tumor Tissue in Local Blood Vessel for Targeted Drug Delivery by Nanorobots

2016 ◽  
Vol 13 (10) ◽  
pp. 6654-6661
Author(s):  
Qingying Zhao ◽  
Min Li ◽  
Jun Luo ◽  
Hanqing Wang ◽  
Jinge Cao

This paper describes a nanorobot control algorithm designed for approaching tumor tissue in local blood vessel for targeted drug delivery. The algorithm coordinates nanorobots’ movements through use of two types of chemical molecules, an acoustic signal and velocity characteristic of blood fluid. After detecting the chemical molecules released by cancer cells, a nanorobot moves toward the area of higher concentration of the molecule and releases another chemical molecule which alerts others to aggregate to the target. When nanorobots detect acoustic signals emitted by nanorobots reaching target, their paths will be planned according to intensity of acoustic signals and velocity characteristic of blood fluid. The simulations show that compared with the existed approaches, the proposed algorithm results in an increase of nanorobots’ population and a decrease of cost time to reach target site with the help of acoustic signals and velocity characteristic. As a whole, the results obtained suggest that the algorithm presented in this paper is a better strategy for approaching tumor tissue in local blood vessel by nanorobots.

2016 ◽  
Vol 17 (1-2) ◽  
Author(s):  
Julia Modrejewski ◽  
Johanna-Gabriela Walter ◽  
Imme Kretschmer ◽  
Evren Kemal ◽  
Mark Green ◽  
...  

AbstractThe purpose of this study was to develop a model system for targeted drug delivery. This system should enable targeted drug release at a certain tissue in the body. In conventional drug delivery systems, drugs are often delivered unspecifically resulting in unwarranted adverse effects. To circumvent this problem, there is an increasing demand for the development of intelligent drug delivery systems allowing a tissue-specific mode of delivery. Within this study, nanoparticles consisting of two biocompatible polymers are used. Because of their small size, nanoparticles are well-suited for effective drug delivery. The small size affects their movement through cell and tissue barriers. Their cellular uptake is easier when compared to larger drug delivery systems. Paclitaxel was encapsulated into the nanoparticles as a model drug, and to achieve specific targeting an aptamer directed against lung cancer cells was coupled to the nanoparticles surface. Nanoparticles were characterized by dynamic light scattering (DLS), transmission electron microscopy (TEM), fourier transform infrared spectroscopy (FTIR), and nanotracking analysis (NTA). Also their surface charge was characterized from ζ-potential measurements. Their preparation was optimized and subsequently specificity of drug-loaded and aptamer-functionalized nanoparticles was investigated using lung cancer cells.


2021 ◽  
Vol 104 ◽  
pp. 93-105
Author(s):  
Sikhumbuzo Charles Kunene ◽  
Kuen-Song Lin ◽  
Meng-Tzu Weng ◽  
Maria Janina Carrera Espinoza ◽  
Chun-Ming Wu

2019 ◽  
Vol 7 (39) ◽  
pp. 6048-6063 ◽  
Author(s):  
Mohd Mughees ◽  
Mohd Samim ◽  
Yadhu Sharma ◽  
Saima Wajid

The shortcomings of the currently available anti-breast cancer agents compel the development of the safer targeted drug delivery for the treatment of breast cancer.


2018 ◽  
Vol 5 (12) ◽  
pp. 181027 ◽  
Author(s):  
Wei Liu ◽  
Yongchao Zhu ◽  
Fan Wang ◽  
Xue Li ◽  
Xiaojing Liu ◽  
...  

Targeted drug delivery to colon cancer cells can significantly enhance the therapeutic efficiency. Herein, we developed 5-fluorouracil (5-FU)-loaded amino-functionalized mesoporous silica nanoparticle (MSN-NH 2 )-based galactosylated chitosans (GCs), which are galactose receptor-mediated materials for colon-specific drug delivery systems. Both unmodified and functionalized nanoparticles were characterized by scanning electron microscopy, transmission electron microscopy, X-ray diffraction, Fourier transform infrared spectroscopy, nitrogen sorption and dynamic light scattering. Drug loading capacity and drug release properties were determined by ultraviolet spectrophotometry. 5-FU@MSN-NH 2 /GC showed high loading capacity and possessed much higher cytotoxicity on human colon cancer cells (SW620 cells) than 5-FU@MSN-NH 2 and free 5-FU. But, MSN-NH 2 /GC did not show significant cytotoxicity. Subsequently, 5-FU@MSN-NH 2 /GC anti-cancer activity on SW620 cells in vitro was confirmed by cell apoptosis. These results are consistent with the cellular uptake test in which MSN-NH 2 /GC could specifically recognize and bind to cancer cells by the galectin-receptor recognition. But, it is found that pre-addition of galactose in the medium, leading to competitive binding to the galectin receptor of SW620 cells, resulted in a decrease in the binding of MSN-NH 2 /GC to the galectin receptor. The results demonstrated the inorganic–organic nanocomposite could be used as a promising drug delivery carrier for the targeted delivery of drug into galectin-positive colon cancer cells to improve therapeutic index while reducing side effects.


2012 ◽  
Vol 24 (21) ◽  
pp. 2798-2798
Author(s):  
Xinjian Yang ◽  
Xia Liu ◽  
Zhen Liu ◽  
Fang Pu ◽  
Jinsong Ren ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document